These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30461645)

  • 1. Dystrophic calcinosis in a patient with overlap syndrome (scleroderma and rheumatoid arthritis) treated by leflunomide: A case report.
    Lee SY; Lee SW; Chung WT
    Medicine (Baltimore); 2018 Nov; 97(47):e13319. PubMed ID: 30461645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystrophic calcinosis with both a huge calcified mass in the cervical spine and calcification in the chest wall in a patient with rheumatoid overlap syndrome.
    Nakamura T; Hirakawa K; Takaoka H; Iyama K
    Clin Rheumatol; 2016 May; 35(5):1403-9. PubMed ID: 24894107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 16-year Follow-up Case of Interstitial Pneumonia with Systemic Sclerosis-rheumatoid Arthritis Overlap Syndrome.
    Yamakawa H; Hagiwara E; Yamanaka Y; Ikeda S; Sekine A; Kitamura H; Baba T; Okudela K; Iwasawa T; Takemura T; Ogura T
    Intern Med; 2017; 56(12):1557-1561. PubMed ID: 28626184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive Calcinosis Cutis inOverlap Syndrome.
    Homsi Y
    Am J Med Sci; 2018 Oct; 356(4):e35. PubMed ID: 30360808
    [No Abstract]   [Full Text] [Related]  

  • 5. Is rituximab an effective treatment of refractory calcinosis?
    Dubos M; Ly K; Martel C; Fauchais AL
    BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27247203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic sclerosis-rheumatoid arthritis overlap syndrome complicated with Sweet's syndrome.
    Zhu T; Zhao WL; Zeng YP; Liu YH; Jin HZ; Li L
    Clin Rheumatol; 2018 Aug; 37(8):2281-2284. PubMed ID: 29802482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive Dystrophic Calcinosis Cutis: A Severe Complication of Polymyositis/Systemic Sclerosis Overlap Syndrome.
    Smith S; Hanson J
    J Clin Rheumatol; 2017 Dec; 23(8):445. PubMed ID: 28926465
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical sodium thiosulfate for calcinosis cutis associated with autoimmune connective tissue diseases: the Mayo Clinic experience, 2012-2017.
    Ma JE; Ernste FC; Davis MDP; Wetter DA
    Clin Exp Dermatol; 2019 Jul; 44(5):e189-e192. PubMed ID: 30251264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis sine scleroderma and calcinosis cutis: report of a rare case.
    Sharma NL; Mahajan VK; Ranjan N; Sharma VC; Gupta M
    Clin Rheumatol; 2010 Feb; 29(2):215-9. PubMed ID: 19834761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and clinical outcomes in Polish patients with high activity rheumatoid arthritis treated with leflunomide (Arava®) in Therapeutic Program: A retrospective analysis of data from the PLUS study.
    Tłustochowicz ME; Kisiel B; Tłustochowicz W
    Adv Clin Exp Med; 2019 Nov; 28(11):1545-1553. PubMed ID: 31660707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystrophic calcinosis in a patient with rheumatoid arthritis.
    Harigane K; Mochida Y; Ishii K; Ono S; Mitsugi N; Saito T
    Mod Rheumatol; 2011 Feb; 21(1):85-8. PubMed ID: 20737189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral leg ulcers secondary to dystrophic calcinosis in a patient with rheumatoid arthritis.
    Hida T; Minami M; Kubo Y
    J Med Invest; 2017; 64(3.4):308-310. PubMed ID: 28955003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral lesion in a patient with calcinosis and arthritis: case report and differential diagnosis.
    Bernstein ML; Neal DC
    J Oral Pathol; 1985 Jan; 14(1):8-14. PubMed ID: 3918155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcinosis cutis associated with connective tissue diseases].
    Fabreguet I; Saurat JH; Rizzoli R; Ferrari S
    Rev Med Suisse; 2015 Mar; 11(466):668-72. PubMed ID: 25962229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity?
    Horimoto AM; da Costa IP
    Rev Bras Reumatol Engl Ed; 2016; 56(4):287-98. PubMed ID: 27476621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.
    Lukas C; Mary J; Debandt M; Daïen C; Morel J; Cantagrel A; Fautrel B; Combe B
    Arthritis Res Ther; 2019 Nov; 21(1):243. PubMed ID: 31730497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between CYB5A gene rs1790834 polymorphism and the response to leflunomide in women with rheumatoid arthritis.
    Łączna M; Malinowski D; Paradowska-Gorycka A; Safranow K; Dziedziejko V; Pawlik A
    Eur J Clin Pharmacol; 2021 Nov; 77(11):1673-1678. PubMed ID: 34160668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis.
    Alfaro-Lara R; Espinosa-Ortega HF; Arce-Salinas CA;
    Reumatol Clin (Engl Ed); 2019; 15(3):133-139. PubMed ID: 28867467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009.
    Balin SJ; Wetter DA; Andersen LK; Davis MD
    Arch Dermatol; 2012 Apr; 148(4):455-62. PubMed ID: 22184719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Felty's syndrome with leflunomide.
    Talip F; Walker N; Khan W; Zimmermann B
    J Rheumatol; 2001 Apr; 28(4):868-70. PubMed ID: 11327265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.